Lemaitre Vascular (LMAT) Receivables (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Receivables data on file, last reported at $35.8 million in Q1 2026.

• Receivables for Q1 2026 came in at $35.8 million, up 1.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $35.8 million (up 1.87% YoY), and the FY2025 annual result was $33.6 million, up 11.8% from the prior year.
• Receivables climbed to $35.8 million in Q1 2026 per LMAT's latest filing, from $33.6 million in the prior quarter.
• Over five years, Receivables peaked at $36.5 million in Q2 2025 and troughed at $20.1 million in Q3 2022.
• A 5-year average of $28.4 million and a median of $30.1 million in 2024 frame the typical range for Receivables.
• The sharpest annual moves came in 2024 and 2025: Receivables soared 35.12% in 2024, then rose 0.46% in 2025.
• A 5-year view of Receivables shows it stood at $22.0 million in 2022, then advanced by 13.72% to $25.1 million in 2023, then rose by 19.94% to $30.1 million in 2024, then gained by 11.8% to $33.6 million in 2025, then increased by 6.43% to $35.8 million in 2026.
• Business Quant data shows LMAT's Receivables at $35.8 million in Q1 2026, $33.6 million in Q4 2025, and $32.4 million in Q3 2025.